June 30, 2025 | December 31, 2024 | ||||||||||
(Unaudited) | |||||||||||
ASSETS | |||||||||||
Current Assets: | |||||||||||
Cash and cash equivalents | $ | 48,166 | $ | 82,840 | |||||||
Restricted cash | 2,740 | 1,882 | |||||||||
Marketable securities | 59,465 | 99,827 | |||||||||
Accounts receivable | 18,457 | 14,272 | |||||||||
Inventory | 18,047 | 14,908 | |||||||||
Prepaid expenses and other current assets | 20,453 | 31,498 | |||||||||
Total current assets | 167,328 | 245,227 | |||||||||
Property and equipment, net | 46,643 | 52,281 | |||||||||
Operating lease right-of-use assets | 20,127 | 31,479 | |||||||||
Intangible assets, net | 13,493 | 15,556 | |||||||||
Goodwill | 3,994 | 3,994 | |||||||||
Other non-current assets | 13,902 | 16,676 | |||||||||
Total assets | $ | 265,487 | $ | 365,213 | |||||||
LIABILITIES, PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 29,714 | $ | 18,972 | |||||||
Accrued and other current liabilities | 31,901 | 31,567 | |||||||||
Operating lease liabilities | 7,572 | 10,049 | |||||||||
Total current liabilities | 69,187 | 60,588 | |||||||||
Debt | 429,679 | 500,516 | |||||||||
Operating lease liabilities, non-current | 14,406 | 24,083 | |||||||||
Other non-current liabilities | 184 | 815 | |||||||||
Total liabilities | 513,456 | 586,002 | |||||||||
Series A preferred stock | 24,210 | — | |||||||||
Stockholders’ deficit: | |||||||||||
Class A common stock | 5 | 3 | |||||||||
Class B common stock | 1 | 1 | |||||||||
Additional paid-in capital | 2,257,171 | 2,204,814 | |||||||||
Accumulated other comprehensive loss | (454) | (295) | |||||||||
Treasury stock | (312,477) | (312,477) | |||||||||
Accumulated deficit | (2,216,425) | (2,112,835) | |||||||||
Total stockholders’ deficit | (272,179) | (220,789) | |||||||||
Total liabilities, preferred stock and stockholders’ deficit | $ | 265,487 | $ | 365,213 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Products | $ | 11,967 | $ | 15,739 | $ | 24,939 | $ | 31,041 | |||||||||||||||
Services | 3,667 | 712 | 9,581 | 6,378 | |||||||||||||||||||
Total revenue | 15,634 | 16,451 | 34,520 | 37,419 | |||||||||||||||||||
Cost of sales: | |||||||||||||||||||||||
Products | 24,124 | 19,969 | 46,954 | 44,476 | |||||||||||||||||||
Services | 3,937 | 10,162 | 8,093 | 17,078 | |||||||||||||||||||
Total cost of sales | 28,061 | 30,131 | 55,047 | 61,554 | |||||||||||||||||||
Gross loss | (12,427) | (13,680) | (20,527) | (24,135) | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research and development | 39,328 | 65,850 | 77,616 | 133,600 | |||||||||||||||||||
Sales and marketing | 5,297 | 12,140 | 10,201 | 26,655 | |||||||||||||||||||
General and administrative | (18,753) | 29,790 | 2,163 | 62,839 | |||||||||||||||||||
Restructuring costs | 1,180 | 6,262 | 1,244 | 6,262 | |||||||||||||||||||
Total operating expenses | 27,052 | 114,042 | 91,224 | 229,356 | |||||||||||||||||||
Loss from operations | (39,479) | (127,722) | (111,751) | (253,491) | |||||||||||||||||||
Other income (expense), net: | |||||||||||||||||||||||
Change in fair value of private warrants | — | 163 | — | 985 | |||||||||||||||||||
Interest expense | (12,255) | (2,757) | (24,576) | (5,514) | |||||||||||||||||||
Interest income | 1,269 | 2,519 | 3,036 | 5,949 | |||||||||||||||||||
Gain on extinguishment of debt | 15,281 | — | 22,056 | — | |||||||||||||||||||
Gain (loss) from acquisition of EM4, LLC (“EM4”) | — | — | (48) | 1,752 | |||||||||||||||||||
Gain from Sale of Investments | 2,908 | — | 2,908 | — | |||||||||||||||||||
Change in fair value of derivative liability | 8,991 | — | 5,320 | — | |||||||||||||||||||
Losses and impairments related to investments and certain other assets, and other income (expense) | 536 | (3,376) | (238) | (5,981) | |||||||||||||||||||
Total other income (expense), net | 16,730 | (3,451) | 8,458 | (2,809) | |||||||||||||||||||
Loss before provision for (benefit from) income taxes | (22,749) | (131,173) | (103,293) | (256,300) | |||||||||||||||||||
Provision for (benefit from) income taxes | 150 | (566) | 297 | 21 | |||||||||||||||||||
Net loss | (22,899) | (130,607) | (103,590) | (256,321) | |||||||||||||||||||
Less: Deemed dividend on Series A preferred stock | 7,602 | — | 7,602 | — | |||||||||||||||||||
Net loss attributable to common stockholders | $ | (30,501) | $ | (130,607) | $ | (111,192) | $ | (256,321) | |||||||||||||||
Net loss per share attributable to common stockholders: | |||||||||||||||||||||||
Basic and diluted | $ | (0.62) | $ | (4.32) | $ | (2.44) | $ | (8.76) | |||||||||||||||
Weighted average shares used in computing net loss per share attributable to common stockholders: | |||||||||||||||||||||||
Basic and diluted | 49,087,995 | 30,242,540 | 45,608,362 | 29,274,792 |
Six Months Ended June 30, | |||||||||||
2025 | 2024 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net loss | $ | (103,590) | $ | (256,321) | |||||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
Depreciation and amortization | 8,772 | 14,458 | |||||||||
Amortization of operating lease right-of-use assets | 3,446 | 4,230 | |||||||||
Amortization of discount on marketable securities | (983) | (1,278) | |||||||||
Loss on marketable securities | 90 | 1,976 | |||||||||
Change in fair value of private warrants | — | (985) | |||||||||
Vendor stock in lieu of cash program | 5,694 | 8,448 | |||||||||
Amortization of debt discount and issuance costs | 3,848 | 1,618 | |||||||||
Inventory write-offs and write-downs | 3,426 | 17,806 | |||||||||
Change in the fair value of derivatives | (5,320) | — | |||||||||
Gain or write-off on sale or disposal of property and equipment | 238 | — | |||||||||
Share-based compensation, including restructuring costs | (1,277) | 83,019 | |||||||||
Gain on extinguishment of debt | (22,056) | — | |||||||||
Impairment of investments | — | 4,000 | |||||||||
Gain (loss) from acquisition of EM4 | 48 | (1,752) | |||||||||
Change in product warranty and other | 4,657 | (2,758) | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | (4,185) | (4,563) | |||||||||
Inventories | (6,863) | (16,098) | |||||||||
Prepaid expenses and other current assets | 11,609 | (1,793) | |||||||||
Other non-current assets | 17,778 | (2,915) | |||||||||
Accounts payable | 9,354 | (1,877) | |||||||||
Accrued and other current liabilities | (7,069) | 916 | |||||||||
Other non-current liabilities | (15,571) | (5,067) | |||||||||
Net cash used in operating activities | (97,954) | (158,936) | |||||||||
Cash flows from investing activities: | |||||||||||
Purchases of marketable securities | (54,154) | (75,051) | |||||||||
Proceeds from maturities of marketable securities | 80,760 | 112,242 | |||||||||
Proceeds from sales/redemptions of marketable securities | 14,490 | 3,737 | |||||||||
Purchases of property and equipment | (226) | (1,586) | |||||||||
Acquisition of EM4 (net of cash acquired) | 242 | (3,831) | |||||||||
Proceeds from disposal of property and equipment | 305 | — | |||||||||
Net cash provided by investing activities | 41,417 | 35,511 | |||||||||
Cash flows from financing activities: | |||||||||||
Net proceeds from issuance of Class A common stock under the Equity Financing Program | 21,461 | 35,903 | |||||||||
Proceeds from sale of Class A common stock under ESPP | 338 | 800 | |||||||||
Proceeds from exercise of stock options | — | 407 | |||||||||
Payments of employee taxes related to stock-based awards | (196) | (216) | |||||||||
Repurchase of 2026 Convertible Notes | (30,297) | — | |||||||||
Proceeds from issuance of Series A preferred stock, net of issuance costs, discount and commitment fees | 31,415 | — | |||||||||
Net cash provided by financing activities | 22,721 | 36,894 | |||||||||
Net decrease in cash, cash equivalents and restricted cash | (33,816) | (86,531) | |||||||||
Beginning cash, cash equivalents and restricted cash | 84,722 | 140,624 | |||||||||
Ending cash, cash equivalents and restricted cash | $ | 50,906 | $ | 54,093 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
GAAP cost of sales | $ | 28,061 | $ | 30,131 | $ | 55,047 | $ | 61,554 | |||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Stock-based compensation | (1,361) | (298) | (2,652) | (3,693) | |||||||||||||||||||
Amortization of intangible assets | (165) | (166) | (394) | (332) | |||||||||||||||||||
Accelerated depreciation related to certain property, plant and equipment items | (143) | (1,295) | (286) | (3,430) | |||||||||||||||||||
Non-GAAP cost of sales | $ | 26,392 | $ | 28,372 | $ | 51,715 | $ | 54,099 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
GAAP gross loss | $ | (12,427) | $ | (13,680) | $ | (20,527) | $ | (24,135) | |||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Stock-based compensation | 1,361 | 298 | 2,652 | 3,693 | |||||||||||||||||||
Amortization of intangible assets | 165 | 166 | 394 | 332 | |||||||||||||||||||
Accelerated depreciation related to certain property, plant and equipment items | 143 | 1,295 | 286 | 3,430 | |||||||||||||||||||
Non-GAAP gross loss | $ | (10,758) | $ | (11,921) | $ | (17,195) | $ | (16,680) |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
GAAP operating expenses | $ | 27,052 | $ | 114,042 | $ | 91,224 | $ | 229,356 | |||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Stock-based compensation | 22,007 | (36,781) | 3,870 | (77,851) | |||||||||||||||||||
Impairment of investments | — | (4,000) | — | (4,000) | |||||||||||||||||||
Restructuring costs | (1,180) | (6,262) | (1,244) | (6,262) | |||||||||||||||||||
Amortization of intangible assets | (866) | (834) | (1,669) | (1,668) | |||||||||||||||||||
Transaction costs relating to acquisition activities | — | (1) | — | (232) | |||||||||||||||||||
Non-GAAP operating expenses | $ | 47,013 | $ | 66,164 | $ | 92,181 | $ | 139,343 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
GAAP net loss attributable to common stockholders | $ | (30,501) | $ | (130,607) | $ | (111,192) | $ | (256,321) | |||||||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Stock-based compensation, excluding restructuring | (20,646) | 37,079 | (1,218) | 81,544 | |||||||||||||||||||
Amortization of intangible assets | 1,031 | 1,000 | 2,063 | 2,000 | |||||||||||||||||||
Accelerated depreciation related to certain property, plant and equipment | 143 | 1,295 | 286 | 3,430 | |||||||||||||||||||
Gain on extinguishment of debt | (15,281) | — | (22,056) | — | |||||||||||||||||||
Impairment of investments | — | 4,000 | — | 4,000 | |||||||||||||||||||
Restructuring costs, including stock-based compensation | 1,180 | 6,262 | 1,244 | 6,262 | |||||||||||||||||||
Gain from acquisition of EM4 | — | — | 48 | (1,752) | |||||||||||||||||||
Transaction costs relating to acquisition activities | — | 1 | — | 232 | |||||||||||||||||||
Change in the fair value of derivative liabilities | (8,991) | — | (5,320) | — | |||||||||||||||||||
Change in fair value of private warrants | — | (163) | — | (985) | |||||||||||||||||||
Non-GAAP net loss attributable to common stockholders | $ | (73,065) | $ | (81,133) | $ | (136,145) | $ | (161,590) | |||||||||||||||
GAAP net loss per share attributable to common stockholders: | |||||||||||||||||||||||
Basic and diluted | $ | (0.62) | $ | (4.32) | $ | (2.44) | $ | (8.76) | |||||||||||||||
Non-GAAP net loss per share attributable to common stockholders: | |||||||||||||||||||||||
Basic and diluted | $ | (1.49) | $ | (2.68) | $ | (2.99) | $ | (5.52) | |||||||||||||||
Shares used in computing GAAP net loss per share attributable to common stockholders: | |||||||||||||||||||||||
Basic and diluted | 49,087,995 | 30,242,540 | 45,608,362 | 29,274,792 | |||||||||||||||||||
Shares used in computing Non-GAAP net loss per share attributable to common stockholders: | |||||||||||||||||||||||
Basic and diluted | 49,087,995 | 30,242,540 | 45,608,362 | 29,274,792 |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
GAAP operating cash flow | $ | (53,725) | $ | (77,707) | $ | (97,954) | $ | (158,936) | ||||||||||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||||||||
Capital expenditure: | ||||||||||||||||||||||||||
Purchases of property and equipment | (111) | (302) | (226) | (1,586) | ||||||||||||||||||||||
Non-GAAP free cash flow | $ | (53,836) | $ | (78,009) | $ | (98,180) | $ | (160,522) |
Three Months Ended June 30, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Stock-Based Compensation | Intangibles Amortization | Stock-Based Compensation | Intangibles Amortization | ||||||||||||||||||||
Cost of Sales | $ | 1,361 | $ | 165 | $ | 298 | $ | 166 | |||||||||||||||
Research and development | 4,792 | 600 | 16,378 | 599 | |||||||||||||||||||
Sales and marketing | 2,109 | 266 | 3,557 | 235 | |||||||||||||||||||
General and administrative | (28,908) | — | 16,846 | — | |||||||||||||||||||
Restructuring costs | (11) | — | 1,412 | — | |||||||||||||||||||
Total | $ | (20,657) | $ | 1,031 | $ | 38,491 | $ | 1,000 |
Six Months Ended June 30, | |||||||||||||||||||||||
2025 | 2024 | ||||||||||||||||||||||
Stock-Based Compensation | Intangibles Amortization | Stock-Based Compensation | Intangibles Amortization | ||||||||||||||||||||
Cost of Sales | $ | 2,652 | $ | 394 | $ | 3,693 | $ | 332 | |||||||||||||||
Research and development | 11,129 | 1,199 | 30,862 | 1,198 | |||||||||||||||||||
Sales and marketing | 3,275 | 470 | 8,780 | 470 | |||||||||||||||||||
General and administrative | (18,274) | — | 38,209 | — | |||||||||||||||||||
Restructuring costs | (59) | — | 1,412 | — | |||||||||||||||||||
Total | $ | (1,277) | $ | 2,063 | $ | 82,956 | $ | 2,000 |